Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combined hepatocellular carcinoma-cholangiocarcinoma: MRI features correlated with tumor biomarkers and prognosis
Changwu Zhou, Yi Wang, Li Ma, et al.
European Radiology (2021) Vol. 32, Iss. 1, pp. 78-88
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 4, pp. 583-705
Open Access | Times Cited: 195
2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma

Korean Journal of Radiology (2022) Vol. 23, Iss. 12, pp. 1126-1126
Open Access | Times Cited: 90
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Journal of Liver Cancer (2022) Vol. 23, Iss. 1, pp. 1-120
Open Access | Times Cited: 83
Clinical value of blood routine and tumor markers in differentiating hepatocellular carcinoma from intrahepatic cholangiocarcinoma
Wei Shi, Jin Wen, Lang Hong, et al.
Medicine (2025) Vol. 104, Iss. 12, pp. e41899-e41899
Open Access
Nomogram based on clinical and preoperative CT features for predicting the early recurrence of combined hepatocellular-cholangiocarcinoma: a multicenter study
Chao Zheng, Xin-Tao Gu, Xiaoli Huang, et al.
La radiologia medica (2023) Vol. 128, Iss. 12, pp. 1460-1471
Open Access | Times Cited: 8
Is it necessary to distinguish between combined hepatocellular carcinoma-cholangiocarcinoma with less than 10% of cholangiocarcinoma components versus hepatocellular carcinoma?
Changwu Zhou, Chun Yang, Mengsu Zeng
Hepatology International (2024)
Closed Access | Times Cited: 3
Combined hepatocellular carcinoma-cholangiocarcinoma with a predominant HCC component: better survival and MRI-based prediction
Yuyao Xiao, Xinde Zheng, Changwu Zhou, et al.
European Radiology (2022) Vol. 33, Iss. 2, pp. 1412-1421
Closed Access | Times Cited: 13
Prognosis of Primary Liver Cancer Based on LI-RADS Classification with Extracellular Agent-Enhanced MRI
Yubo Li, Xiaoyan Ni, Xinai Liu, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 399-411
Open Access | Times Cited: 7
Histopathological components correlated with MRI features and prognosis in combined hepatocellular carcinoma-cholangiocarcinoma
Changwu Zhou, Xin Lu, Yi Wang, et al.
European Radiology (2022) Vol. 32, Iss. 10, pp. 6702-6711
Closed Access | Times Cited: 10
Rare histotypes of epithelial biliary tract tumors: A literature review
Elena Sapuppo, Oronzo Brunetti, Dalila Tessitore, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 181, pp. 103892-103892
Open Access | Times Cited: 10
The Fibrinogen/Albumin Ratio Index as an Independent Prognostic Biomarker for Patients with Combined Hepatocellular Cholangiocarcinoma After Surgery
Jiake Xu, Shao‐Chun Li, Feng Ye, et al.
Cancer Management and Research (2022) Vol. Volume 14, pp. 1795-1806
Open Access | Times Cited: 9
Risk stratification of LI-RADS M and LI-RADS 4/5 combined hepatocellular cholangiocarcinoma: prognostic values of MR imaging features and clinicopathological factors
Yi Wang, Guiqi Zhu, Changwu Zhou, et al.
European Radiology (2022) Vol. 32, Iss. 8, pp. 5166-5178
Closed Access | Times Cited: 8
Apparent Diffusion Coefficient MRI Shows Association With Early Progression of Unresectable Intrahepatic Cholangiocarcinoma With Combined Targeted‐Immunotherapy
Ruofan Sheng, Wei Sun, Xiaoyong Huang, et al.
Journal of Magnetic Resonance Imaging (2022) Vol. 57, Iss. 1, pp. 275-284
Closed Access | Times Cited: 8
Non-invasive imaging in the diagnosis of combined hepatocellular carcinoma and cholangiocarcinoma
Yuting Shen, Wenwen Yue, Huixiong Xu
Abdominal Radiology (2023) Vol. 48, Iss. 6, pp. 2019-2037
Closed Access | Times Cited: 3
Prediction of microvascular invasion in combined hepatocellular-cholangiocarcinoma based on preoperative contrast-enhanced CT and clinical data
Juan Zhang, Wei Dong, Yinqiao Li, et al.
European Journal of Radiology (2023) Vol. 163, pp. 110839-110839
Open Access | Times Cited: 3
Prognostic and pathological implications of contrast-enhanced ultrasound features in hepatocellular carcinoma
Yuling Wang, Suwan Chai, Wenjia Cai, et al.
Journal of Cancer Research and Therapeutics (2023) Vol. 19, Iss. 4, pp. 1040-1047
Open Access | Times Cited: 3
Meta-analysis of prognostic factors for overall survival and disease-free survival among resected patients with combined hepatocellular carcinoma and cholangiocarcinoma
Tian‐Run Lv, Hai‐Jie Hu, Wenjie Ma, et al.
European Journal of Surgical Oncology (2023) Vol. 50, Iss. 1, pp. 107279-107279
Closed Access | Times Cited: 3
Contrast-enhanced MRI could predict response of systemic therapy in advanced intrahepatic cholangiocarcinoma
Ruofan Sheng, Xiaoyong Huang, Kaipu Jin, et al.
European Radiology (2022) Vol. 32, Iss. 8, pp. 5156-5165
Closed Access | Times Cited: 5
Multimodality imaging of hepatocellular carcinoma and intrahepatic cholangiocarcinoma
Haneyeh Shahbazian, Mohammad Mirza‐Aghazadeh‐Attari, Ali Borhani, et al.
Journal of Surgical Oncology (2023) Vol. 128, Iss. 4, pp. 519-530
Closed Access | Times Cited: 2
The role of radiomics in hepato-bilio-pancreatic surgery: a literature review
Riccardo De Robertis, Marco Todesco, Daniele Autelitano, et al.
Artificial Intelligence Surgery (2023) Vol. 3, Iss. 3, pp. 166-79
Open Access | Times Cited: 2
How to differentiate between combined hepatocellular carcinoma-cholangiocarcinoma and intrahepatic cholangiocarcinoma with rim arterial phase hyperenhancement?
Changwu Zhou, Peng Huang, Fei Wu, et al.
Abdominal Radiology (2024) Vol. 49, Iss. 9, pp. 3015-3023
Closed Access
MRI features of combined hepatocellular-cholangiocarcinoma
Noor Fatima Majeed, Mathew Macey, Marta Braschi Amirfarzan, et al.
Abdominal Radiology (2024)
Closed Access
Study on the clinical value of MRI imaging in diagnosis of primary hepatocellular carcinoma with different pathological types
Yong Ping, Zhigang Li, Yazhou Li, et al.
Asian Journal of Surgery (2024)
Open Access
Prognostic Impact of CCA Components in Combined Hepatocellular Carcinoma-Cholangiocarcinoma
Zhu Zhu, Chun Yang, Mengsu Zeng, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 2483-2492
Open Access
Solitary hypovascular hepatic nodules: comparison and differentiation between peripheral nodular cholangiocarcinoma and atypical liver hemangioma with MRI
Han Wang, Shengren Guo
Translational Cancer Research (2023) Vol. 12, Iss. 9, pp. 2308-2318
Open Access
Page 1 - Next Page

Scroll to top